Barclays »

60 Degrees Pharmaceuticals I shares owned by Barclays

Quarter-by-quarter ownership of 60 Degrees Pharmaceuticals I (SXTP) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in 60 Degrees Pharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including 60 Degrees Pharmaceuticals I held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 60 Degrees Pharmaceuticals I by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $769 1.5k 0.51

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corp Opt Put Option (MSFT)
Apple (AAPL)
Ishares Tr Opt Call Option (IWM)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Opt Put Option (HYG)
Advanced Micro Devices (AMD)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding 60 Degrees Pharmaceuticals I

Jane Street
Geode Capital Management
Tower Research Capital
Barclays
UBS Group
Advisor Group Holdings

View all funds holding 60 Degrees Pharmaceuticals I